semaglutide chf in Heart Failure With Preserved Ejection Fraction: Emerging Evidence and Clinical Implications STEP Study: Semaglutide's Impact on

The drug is known as a triple-agonist, meaning it targets three different receptors in the brain and throughout the body

The decision to continue, reduce, or stop semaglutide should be made with your healthcare provider based on symptom severity, the benefit you are receiving from the medication, and alternative management options

Stratified by baseline weight or BMI Subgroup analyses were performed bounded by the weighted median of baseline weight (105.6 kg)

The competition was on: Manufacturers raced to secure Health Canada approval so they could begin making generic versions of the drug, driving down the cost and disrupting the stronghold name brands like Wegovy and Ozempic have on the diabetes and weight-loss market